Sort
8,912 grants matching “sars cov 2”
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events
$870,905Robert Yeh · Beth Israel Deaconess Medical Center · R01 · FY2022 · HL
Balancing epithelial cell resistance and resilience to respiratory viral infections
$869,852Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2023 · HL
Core A: Clinical
$869,489Suphamai Bunnapradist · University Of California Los Angeles · U19 · FY2020 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients - Clinical Core
$869,489Elaine F Reed · University Of California Los Angeles · U19 · FY2020 · AI
COVID-19 Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)
$869,057Daniel K Benjamin · Duke University · U24 · FY2020 · TR
Genetic Investigation of Covid 19 in Lung Disease
$869,001Mark L Kahn · University Of Pennsylvania · R01 · FY2024 · HL
Characterization of Persistent COVID-19
$868,661Jonathan Li · Brigham And Women'S Hospital · R01 · FY2023 · AI
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$868,549John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
BRAIN-2 COVID-19 Administrative Supplement
$868,245E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2020 · AG
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$868,039Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2022 · GM
NINDS Quantitative MRI Core Facility
$867,749Govind Nair · National Institute Of Neurological Disorders And Stroke · ZIC · FY2024 · NS
Synergistic Nanobodies for Pandemic Preparedness
$867,563Michael P Rout · Rockefeller University · R01 · FY2025 · AI
Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable
$867,269Mark R Denison · University Of Alabama At Birmingham · U19 · FY2018 · AI
Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD
$866,527Adam Peter Spira · Johns Hopkins University · R01 · FY2025 · AG
Regulation of Protein C Pathways
$865,960Laurent Olivier Mosnier · Scripps Research Institute, The · R01 · FY2022 · HL
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events
$865,807Robert Yeh · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL
Assessing Diabetes Risk Origins in Teens (ADROIT)
$865,708Lorraine E Katz · Children'S Hosp Of Philadelphia · U01 · FY2024 · DK
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
$865,682Charles Bix Shoemaker · Tufts University Boston · R01 · FY2023 · AI
Regulation of Protein C Pathways
$865,376Laurent Olivier Mosnier · Scripps Research Institute, The · R01 · FY2024 · HL
Human pluripotent stem cells
$865,069Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2021 · NS
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19
$863,810Charles Yen Chiu · University Of California, San Francisco · R61 · FY2021 · HD
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$863,551John Ross Teijaro · Scripps Research Institute, The · R01 · FY2025 · AI
RNA: New Antimicrobial Strategies
$863,503Adrian Ferrã-D'amarã · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Development of vaccination strategies to elicit broadly protective immunity against influenza
$862,508Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2024 · AI
Ultrafast Biophysical Studies of Biomolecules at the APS
$861,982Philip Anfinrud · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK